Načítá se...
Bisphosphonate therapy for osteogenesis imperfecta
BACKGROUND: Osteogenesis imperfecta is caused by a genetic defect resulting in an abnormal type I collagen bone matrix which typically results in multiple fractures with little or no trauma. Bisphosphonates are used in an attempt to increase bone mineral density and reduce these fractures in people...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2016
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6611487/ https://ncbi.nlm.nih.gov/pubmed/27760454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005088.pub4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|